Effect of morphine-sensitization in D2 receptor gene expression in the mice brain in the absence and presence of lithium chloride

Yakhteh

Volumn 12, Issue 3, 2010, Pages 395-404

  Mehregan, Hoda ^a   Sadeghizadeh, Majid ^a   Zarrindast, Mohammad Reza ^b   Azadmanesh, Kayhan ^c   Jahanshahi, Ali ^a   Shirzad, Hadi ^d   Saadati, Mojtaba ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d Imam Hossein Hospital   (Iran)

Author keywords

D2 receptor; Gene expression; Lithium chloride; Morphine sensitization; Real Time pcr

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; LITHIUM CHLORIDE; MORPHINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIZATION; GENE EXPRESSION; HIPPOCAMPUS; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; REAL TIME POLYMERASE CHAIN REACTION;

EID: 78650455059     PISSN: 15614921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993; 18(3): 247-291.
2. Richtand NM. Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function. Neuropsychopharmacology. 2006; 31(11): 2368-2375.
3. Kuribara H. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol. 1995; 275(3): 251-258.
4. Serrano A, Aguilar MA, Manzanedo C, RodriguezArias M, Miñarro J. Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26(7-8): 1263-1271.
5. Jeziorski M, White FJ. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol 1995; 275(3): 235-244.
6. Abrahamson JR. Use of lithium to control drug abuse. Am J Psychiatry. 1983; 140(9): 1256.
7. Dehpour AR, Farsam H, Azizabadi-Farahani M. Inhibition of the morphine withdrawal syndrome and the development of physical dependence by lithium in mice. Neuropharmacology. 1995; 34(1): 115-121.
8. Liebman JM, Segal DS. Lithium differentially antagonises self-stimulation facilitated by morphine and (+)-amphetamine. Nature, 1976; 260(5547): 161-163.
9. Dehpour AR, Farsam H, Azizabadi-Farahani M. The effect of lithium on morphine-induced analgesia in mice. Gen Pharmacol. 1994; 25(8): 1635-1641.
10. Johnston IN, Westbrook RF. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors. Behav Brain Res. 2004; 151(1-2): 151-158.
11. Carroll BJ, Sharp PT. Rubidium and lithium: opposite effects on amine-mediated excitement. Science. 1971; 172(990): 1355-1357.
12. You ZD, Li JH, Song CY, Lu CL, He C. Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats. Neurosci Res. 2001; 41(2): 143-150.
13. O'Donnell KC, Gould TD. The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci Biobehav Rev. 2007; 31(6): 932-962.
14. de Gandarias JM, Acebes I, Echevarría E, Vegas L, Abecia LC, Casis L. Lithium alters mu-opioid receptor expression in the rat brain. Neurosci Lett. 2000. 279(1): 9-12.
15. Sharma SK, Klee WA, Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA. 1975; 72(8): 3092-3096.
16. Ikonomov OC, Manji HK. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. Am J Psychiatry. 1999; 156(10): 1506-1514.
17. Li PP. Transcriptional mechanisms of lithium action: therapeutic implications. Clinical Neuroscience Research. 2004; 4: 271-280.
18. Dziedzicka-Wasylewska M, Wedzony K. The effect of prolonged administration of lithium on the level of dopamine D2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp (Wars). 1996; 56(1): 29-34.
19. Bozzi, Y, Borrelli E. Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci. 2006; 29(3): 167-174.
20. Rani M, Kanungo MS. Expression of D2 dopamine receptor in the mouse brain. Biochem Biophys Res Commun. 2006; 344(3): 981-986.
21. Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, Borrelli E. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci. 2002; 22(8): 3293-3301.
22. Monsma FJ Jr, McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature. 1989; 342(6252): 926-929.
23. Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, et al. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci USA. 2003; 100(7): 4305-4309.
24. Zarrindast MR, Fazli-Tabaei S, Ahmadi S, Yahyavi SH. Effect of lithium on morphine state dependent memory of passive avoidance in mice. J Physio Behav. 2006; 87:409-415.
25. Sahraei H, Faghih-Monzavi Z, Fatemi SM, PashaeiRad S, Salimi SH, Kamalinejad M. Effect of papaver rhoeas Extract on the acquisition and expression of morphine-induced behavioral sensitization in mice. Phytother Res. 2006; 20: 737-741.
26. Giordano TP 3rd, Satpute SS, Striessnig J, Kosofsky BE, Rajadhyaksha AM. Up-regulation of dopamine D(2) L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. J Neurochem. 2006; 99(4): 1197-1206.
27. Spanagel R, Almeida OF, Shippenberg TS. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse. 1993; 14(3): 243-245.
28. Nestby P, Vanderschuren LJ, De Vries TJ, Hogenboom F, Wardeh G, Mulder AH, et al. Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychopharmacology (Berl). 1997; 133(1): 69-76.
29. Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 2000; 151(2-3): 99-120.
30. Sibley DR, Neve KA. The Dopamine Receptors. In: Neve KA, Neve RL (eds). Totowa, NJ, US: Humana Press Inc; 1997; 383-424.
31. Namkung Y, Sibley DR. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J Biol Chem. 2004; 279(47): 49533-49541.
32. Narita M, Mizuo K, Shibasaki M, Narita M, Suzuki T. Up-regulation of the G(q/11alpha) protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion. Neuroscience. 2002; 111(1): 127-132.
33. Kameda K, Miura J, Suzuki K, Kusumi I, Tanaka T, Koyama T. Effects of lithium on dopamine D2 receptor expression in the rat brain striatum. J Neural Transm. 2001; 108(3): 321-334.
34. Valdenaire O, Vernier P, Maus M, Dumas Milne Edwards JB, Mallet J. Transcription of the rat dopamineD2-receptor gene from two promoters. Eur J Biochem. 1994; 220(2): 577-584.
35. Yuan PX, Chen G, Huang LD, Manji HK. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Brain Res Mol Brain Res. 1998; 58(1-2): 225-230.
36. Ozaki N , Chuang DM. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem. 1997; 69(6): 2336-2344.
37. Wang J, Miller JC, Friedhoff AJ. Differential regulation of D2 receptor gene expression by transcription factor AP-1 in cultured cells. J Neurosci Res. 1997; 50(1): 23-31.
38. Jope RS. A bimodal model of the mechanism of action of lithium. Mol Psychiatry. 1999; 4(1): 21-25.
39. Dziedzicka-Wasylewska M, Mackowiak M, Fijat K, Wedzony K. Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. J Neural Transm. 1996; 103(7): 765-767.